• Sulfaphenazole: Beyond CYP2C9 Inhibition in Ischemia and Wou

  2026-07-13

  Discover how Sulfaphenazole, a selective CYP2C9 inhibitor, uniquely advances research in ischemia-reperfusion injury and wound healing beyond traditional drug metabolism studies. Explore actionable insights for vascular, antibacterial, and translational applications.

• G-Quadruplexes Modulate TDP-43 Condensation and Toxicity

  2026-07-13

  Oldani et al. (2025) reveal that RNA G-quadruplexes (G4s) can directly influence the aggregation, distribution, and cytotoxicity of TDP-43, a protein central to neurodegenerative disorders like ALS. This work pioneers the mechanistic link between RNA secondary structure and protein misfolding, highlighting the therapeutic promise of targeting G4s for disease modification.

• Dissecting Drug Responses: Advances in In Vitro Cancer Evalu

  2026-07-12

  Schwartz's dissertation introduces a refined framework for distinguishing between proliferative arrest and cell death in in vitro cancer drug testing. This methodological advance enables a more accurate assessment of kinase inhibitors, improving the interpretive value of preclinical drug response data.

• tRF16-ALKBH5 Axis Modulates Osteoarthritis via m6A Regulatio

  2026-07-10

  This study uncovers a novel role for the tRNA-derived fragment tRF16 in osteoarthritis (OA) progression, demonstrating that tRF16 directly downregulates the m6A demethylase ALKBH5, destabilizing NFKBIA mRNA and activating NF-κB signaling. The findings highlight the tRF16-ALKBH5-NFKBIA pathway as a potential biomarker and therapeutic target for OA, providing mechanistic insight into post-transcriptional and epigenetic regulation in joint disease.

• Moxidectin: Beyond Anthelmintics—Enabling Next-Gen Antifunga

  2026-07-09

  Explore the multifaceted role of moxidectin, a macrocyclic lactone anthelmintic, in both advanced parasitic worm control and as a synergist in antifungal polyene therapies. This article reveals unique mechanistic insights and practical assay implications not covered in other reviews.

• Applied ddhCTP: Antiviral Workflows & RNA Virus Replication

  2026-07-09

  ddhCTP (3ʹ-deoxy-3′,4ʹ-didehydro-CTP) empowers precise, mechanism-driven inhibition of viral RNA synthesis in both cellular and in vitro systems. This guide translates breakthrough mechanistic insights and the latest protocol refinements into actionable steps for robust antiviral assay deployment and troubleshooting.

• PFHxS Triggers Hepatotoxicity via PPARα in Zebrafish Larvae

  2026-07-08

  This study reveals that perfluorohexanesulfonic acid (PFHxS), a short-chain PFAS, induces hepatotoxicity in developing zebrafish by activating the PPARα pathway. The findings clarify the mechanistic link between PFHxS exposure and liver dysfunction, providing a model for investigating environmental and metabolic disease risks.

• ALDOB K87 Lactylation Drives Mitochondrial Fission in PH

  2026-07-08

  This study reveals that lactylation of aldolase B at lysine 87 orchestrates mitochondrial fission and metabolic reprogramming in pulmonary hypertension (PH). By connecting hypoxia-driven metabolic changes to pathological smooth muscle cell proliferation, the findings offer new mechanistic insights and potential therapeutic targets for vascular remodeling.

• CXCR4-Targeted Theranostics: Imaging and Therapy in Lymphoma

  2026-07-07

  This review details recent advances in CXCR4-targeted imaging and therapeutic ligands for lymphoma, highlighting their mechanistic rationale and translational potential. By integrating molecular imaging with CXCR4 inhibition, the reference study outlines a pathway toward more precise diagnosis and individualized treatment strategies for hematologic malignancies.

• SU5416 (Semaxanib): Precision VEGFR2 Inhibition for Advanced

  2026-07-07

  Explore the multifaceted scientific applications of SU5416 (Semaxanib), a highly selective VEGFR2 inhibitor, in dissecting angiogenesis and immune modulation in cancer and vascular research. This article offers a unique, protocol-focused perspective and integrates new insights from recent pulmonary hypertension studies.

• CXCR4-Targeted Theranostics in Lymphoma: Imaging and Therapy

  2026-07-06

  This review highlights recent advances in integrating CXCR4-targeted imaging ligands and therapeutic antagonists for lymphoma. By elucidating the link between CXCR4 overexpression and disease progression, the study informs the development of precision diagnostics and targeted interventions that may enhance prognosis and treatment response.

• Modeling HSV-1 Latency in Human iPSC-Derived Sensory Neurons

  2026-07-06

  This study establishes a scalable protocol for differentiating human inducible pluripotent stem cells into functional sensory neurons and validates their use as a model for latent herpes simplex virus 1 infection and reactivation. The findings enable direct investigation of HSV-1 latency mechanisms in human neurons, addressing a major gap left by animal models.

• Cefoperazone Sodium Salt in Antimicrobial Research Workflows

  2026-07-05

  Cefoperazone sodium salt delivers robust, β-lactamase-stable antibacterial activity, making it a standout tool for modeling gram-negative resistance and biliary tract infection research. This guide translates primary literature findings into actionable workflows, with troubleshooting and optimization tips for reproducible, high-impact antimicrobial assays.

• hiPSC-Derived Intestinal Organoids for Pharmacokinetic Resea

  2026-07-04

  The referenced study introduces a streamlined protocol for generating human intestinal organoids from pluripotent stem cells, enabling advanced pharmacokinetic analysis in a human-relevant system. This innovation addresses limitations of traditional models and provides a reproducible platform for evaluating drug absorption and metabolism.

• Bestatin-Induced Endothelial Invasion in Fibrin: Rethinking

  2026-07-03

  This study uncovers that bestatin, an aminopeptidase inhibitor, unexpectedly stimulates microvascular endothelial cell invasion and capillary-like tube formation in a fibrin matrix. The findings challenge the established anti-angiogenic paradigm of bestatin and highlight complex aminopeptidase roles in tumor-associated stroma, with practical implications for experimental design in angiogenesis and multidrug resistance research.

16957 records 1/1131 page Next 12345 下5页 Last page